Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Waste Data Preview
In 2023, Ionis Pharmaceuticals conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into Ionis Pharmaceuticals's Waste Treatment Practices
In 2023, Ionis Pharmaceuticals generated a total of 634 metric tonnes of waste.
Of this amount, 25.87% of Ionis Pharmaceuticals's total waste generated was recovered through methods such as recycling, reuse, or composting, while 35.17% was disposed of through landfilling, incineration, or combustion. The remaining 38.96% was either treated using unspecified methods or not clearly categorized.
Ionis Pharmaceuticals's Waste Recovery Rate
How much of Ionis Pharmaceuticals's waste is recycled or recovered?
In 2023, Ionis Pharmaceuticals reported a total waste generation of 634 metric tonnes, of which 25.87% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Ionis Pharmaceuticals is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Has Ionis Pharmaceuticals reduced its environmental waste footprint over time?
Since 2021, Ionis Pharmaceuticals's total waste generation decreased by 6.63%, and remained stable in 2023, which may indicate a new baseline following earlier reductions in waste output.
Over the same period, Ionis Pharmaceuticals's waste recovery rate increased by 18.68%, including a 6.66% rise in 2023, indicating growing emphasis on circularity and improved operational practices for diverting waste from disposal.
Overall, Ionis Pharmaceuticals appears to have stabilized its waste output following a period of long-term reduction, while continuing to improve its recovery practices. This suggests consolidation of earlier gains with stronger waste treatment efforts.
Ionis Pharmaceuticals’s Waste Recovery vs. Disposal Over Time
- Total Waste Disposed
- Total Waste Recovered
Insights into Ionis Pharmaceuticals’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Ionis Pharmaceuticals generated a total of 634 metric tonnes of waste.
Of this amount, 38.96% of Ionis Pharmaceuticals's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 61.04% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Ionis Pharmaceuticals’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Ionis Pharmaceuticals reduced the environmental impact of its waste?
Since 2021, Ionis Pharmaceuticals's total waste generation decreased by 6.63%, and remained stable in 2023, signaling a plateau following previous reductions that may mark a new waste baseline.
Over the same period, Ionis Pharmaceuticals reduced the hazardousness of its waste by 4.5%, with a further 6.65% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.
Overall, Ionis Pharmaceuticals's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.